Effect of Nebulized Bronchodilators on Heart Rate

Completed · Phase 4

Conditions studied: COPD, Sepsis, Shock

In brief

The purpose of the study is to determine adverse events rates of nebulized albuterol versus levalbuterol among adult critically ill patients and determine if a differential exists in adverse events between the two drugs.

Key facts

Study ID

NCT01151579

Run by

Fahim Khorfan, MD

People needed

89

Starts

2008-12-01

Expected to finish

2009-11-01

Last updated by the study team

2015-10-23

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Adults who required inhaled bronchodilator therapy in the form of short acting beta adrenergic receptor agonist and short acting anti-cholinergic treatment every 4-6 hours for respiratory functions

You may not qualify if…

• Known allergy or sensitivity to study medications
• Baseline heart rate was greater than 110 beats per minute

Where it is running

• Genesys Regional Medical Center — Grand Blanc, Michigan, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.